Examining the Association Between Ruxolitinib and Aggressive Cutaneous Squamous Cell Carcinoma: Is There a Justified Need for Screening Programs?

• F. Gruber-Velasco,
• M. Dorado-Fernandéz,
• N. Silvestre-Torner,
• B. Jiménez-Romero,
• C. Axpe-Gil,
• E. Vargas-Laguna,
• A. López-Martín,
• M. Goizueta,
• P. García Vicente

Affiliations

F. Gruber-Velasco

Hospital Universitario Severo Ochoa, Department of Dermatology, Leganés, Spain

M. Dorado-Fernandéz

Hospital Universitario Severo Ochoa, Department of Dermatology, Leganés, Spain

N. Silvestre-Torner

Hospital Universitario Severo Ochoa, Department of Dermatology, Leganés, Spain

B. Jiménez-Romero

Hospital Universitario Severo Ochoa, Department of Dermatology, Leganés, Spain

C. Axpe-Gil

Hospital Universitario Severo Ochoa, Department of Dermatology, Leganés, Spain

E. Vargas-Laguna

Hospital Universitario Severo Ochoa, Department of Dermatology, Leganés, Spain

A. López-Martín

Hospital Universitario Severo Ochoa, Department of Oncology, Leganés, Spain

M. Goizueta

Hospital Universitario Severo Ochoa, Department of Hematology, Leganés, Spain

P. García Vicente

Hospital Universitario Severo Ochoa, Department of Otorhinolaryngology, Leganés, Spain